\section*{Introduction}

The Australian Ovarian Cancer Study (AOCS) performed whole genome sequencing on 96 Ovarian cancer tumors, including 12 donors with both primary and recurrence samples. Here we analyze the neoantigen burden burden of these paired tumors 